Uptake of Biosimilar Insulin Aspart Following Implementation of a Regional Prescribing Policy Intervention; An Interrupted Time Series Analysis (dataset)
Background: Biosimilar insulin prescribing policy interventions offer the opportunity for healthcare systems to make substantial financial savings through both new initiations and active switching from reference products, without adverse effects on patient outcomes. In September 2024, a large integrated care board in n...
Ben Hindley, Louise C. Cope, Phillipa McCabe et al.
· Liverpool John Moores Univer... · 0 citations